Low Dose Peri- Operative Intra Venous Teranexamic Acid Reduces Blood Loss After Total Knee Arthroplasty: A Double Blind Randomized Placebo Controlled Clinical Trial

Total Knee Arthroplasty (TKA) is a common orthopedic surgery usually leads to Bleeding. The null hypothesis of this study was that TA has no effect on post surgical bleeding in patients undergoes TKA.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Knee Arthroplasty, Total

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Amin Nemati

Isfahan, 8158119749, Iran

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Individuals with osteoarthritis who indicated for primary TKA.

Exclusion criteria

Previous history of ceberovascular diseases
Previous history of myocardial infarction
Candidates for bilateral TKA

Treatment and study plan

Tranexamic Acid

Drug

normal saline

Drug

Primary outcomes

Hb Level 48 Hours After Total Knee Arthroplasty

Time frame: 48 hours after TKA

Sponsors and collaborators

Lead sponsor

Isfahan University of Medical Sciences

Other

Registry information

Important dates

Study start: 2013
Primary completion: 2015
First posted: Dec 30, 2014
Registry last updated: Jul 22, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed